LeadIQ logo
Learn more at LeadIQ.com
✕

Access Insights for BioNTech SE and Millions of Other Companies

Sign up for full access to BioNTech SE information.
No credit card needed
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

Insights

mRNA Vaccine Expertise BioNTech is a leader in mRNA vaccine development with deep expertise and in-house manufacturing capabilities. This positions the company well to capitalize on the growing demand for mRNA-based therapies in the healthcare industry.

Public Health Emergency Preparedness BioNTech has shown readiness to respond to public health emergencies by dedicating a significant portion of its manufacturing capacity to produce mRNA vaccines in such situations. This commitment presents an opportunity for partnerships with governments and public health organizations.

Talent Acquisition and Expansion BioNTech's strategic hiring of key executives like a Chief Commercial Officer and a Chief Legal Officer indicates a focus on strengthening its leadership team. This emphasis on top talent acquisition suggests growth plans and potential collaboration opportunities.

Financial Stability and Growth Potential With a substantial revenue base and strong funding of $145M, BioNTech demonstrates financial stability and growth potential. This stability can attract investors and partners looking to engage with a financially secure and expanding biotechnology company.

Legal Disputes and Competitive Positioning BioNTech's involvement in legal disputes over COVID-19 vaccine patents and royalties calls for a strategic review of its competitive positioning in the market. Sales professionals can leverage these challenges to offer innovative solutions and build stronger alliances in the biotechnology sector.

Similar companies to BioNTech SE

✕

Access Insights for BioNTech SE and Millions of Other Companies

Sign up for full access to BioNTech SE information.
No credit card needed
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

BioNTech SE Tech Stack

BioNTech SE uses 8 technology products and services including QlikView, Zendesk, IBM Watson, and more. Explore BioNTech SE's tech stack below.

  • QlikView
    Business Intelligence
  • Zendesk
    Documentation Tools
  • IBM Watson
    IT Infrastructure
  • UNIX
    Operating Systems
  • Pantheon
    Platform As A Service
  • Yoast SEO
    Search Engines
  • Base SAS
    Software As A Service
  • Twitter
    Widgets

Media & News

BioNTech SE's Email Address Formats

BioNTech SE uses at least 1 format(s):
BioNTech SE Email FormatsExamplePercentage
First.Last@biontech.deJohn.Doe@biontech.de
92%
FLast@biontech.deJDoe@biontech.de
3%
First.Last@biontech.deJohn.Doe@biontech.de
3%
First.Last@biontech.deJohn.Doe@biontech.de
2%

Frequently Asked Questions

Where is BioNTech SE's headquarters located?

Minus sign iconPlus sign iconBioNTech SE's main headquarters is located at An der Goldgrube 12 Mainz, Rhineland-Palatinate 55131 DE. The company has employees across 6 continents, including EuropeNorth AmericaAsia.

What is BioNTech SE's phone number?

Minus sign iconPlus sign icon You can contact BioNTech SE's main corporate office by phone at
✕

Access Insights for BioNTech SE and Millions of Other Companies

Sign up for full access to BioNTech SE information.
No credit card needed
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
+49-6131-9****
. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is BioNTech SE's stock symbol?

Minus sign iconPlus sign iconBioNTech SE is a publicly traded company; the company's stock symbol is BNTX.

What is BioNTech SE's official website and social media links?

Minus sign iconPlus sign iconBioNTech SE's official website is biontech.de and has social profiles on LinkedIn.

How much revenue does BioNTech SE generate?

Minus sign iconPlus sign icon As of September 2024, BioNTech SE's annual revenue reached $18B.

What is BioNTech SE's SIC code NAICS code?

Minus sign iconPlus sign iconBioNTech SE's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does BioNTech SE have currently?

Minus sign iconPlus sign iconAs of September 2024, BioNTech SE has approximately 4.8K employees across 6 continents, including EuropeNorth AmericaAsia. Key team members include Chief Executive Officer & Co-Founder: U. S.Chief Operating Officer: S. P.Chief Financial Officer: J. H.. Explore BioNTech SE's employee directory with LeadIQ.

What industry does BioNTech SE belong to?

Minus sign iconPlus sign iconBioNTech SE operates in the Biotechnology Research industry.

What technology does BioNTech SE use?

Minus sign iconPlus sign iconBioNTech SE's tech stack includes QlikViewZendeskIBM WatsonUNIXPantheonYoast SEOBase SASTwitter.

What is BioNTech SE's email format?

Minus sign iconPlus sign iconBioNTech SE's email format typically follows the pattern of . Find more BioNTech SE email formats with LeadIQ.

How much funding has BioNTech SE raised to date?

Minus sign iconPlus sign icon As of September 2024, BioNTech SE has raised $145M in funding. The last funding round occurred on May 29, 2024 for $145M.

When was BioNTech SE founded?

Minus sign iconPlus sign iconBioNTech SE was founded in 2008.
BioNTech SE

BioNTech SE

Biotechnology ResearchRhineland-Palatinate, Germany1001-5000 Employees

BioNTech is a global next generation immunotherapy company aspiring to translate science into survival. Around 6.100 pioneers currently work with us, employing a wide array of computational discovery and therapeutic drug platforms for the rapid development of novel biopharmaceuticals. Our broad portfolio of oncology product candidates includes individualized and off-the-shelf mRNA-based therapies, innovative chimeric antigen receptor (CAR) T cells, several protein-based therapeutics, including bispecific immune checkpoint modulators, targeted cancer antibodies and antibody-drug conjugate (ADC) therapeutics, as well as small molecules. 
  
Based on our deep expertise in mRNA vaccine development and in-house manufacturing capabilities, we are developing multiple mRNA vaccine candidates for a range of infectious diseases alongside its diverse oncology pipeline. 

To learn more about us, please visit www.BioNTech.com. 

Our privacy statement can be found here:  https://www.biontech.com/int/en/home/data-privacy-statement.html

✕

Access Insights for BioNTech SE and Millions of Other Companies

Sign up for full access to BioNTech SE information.
No credit card needed
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

Section iconCompany Overview

Headquarters
An der Goldgrube 12 Mainz, Rhineland-Palatinate 55131 DE
Phone number
✕

Access Insights for BioNTech SE and Millions of Other Companies

Sign up for full access to BioNTech SE information.
No credit card needed
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
+49-6131-9****
Website
biontech.de
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
BNTX
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2008
Employees
1001-5000

Section iconMedia & News

Section iconFunding & Financials

  • $145M

    BioNTech SE has raised a total of $145M of funding over 10 rounds. Their latest funding round was raised on May 29, 2024 in the amount of $145M.

  • $1B

    BioNTech SE's revenue is in the range of $1B

Section iconFunding & Financials

  • $145M

    BioNTech SE has raised a total of $145M of funding over 10 rounds. Their latest funding round was raised on May 29, 2024 in the amount of $145M.

  • $1B

    BioNTech SE's revenue is in the range of $1B

Company Leadership

Employee Directory

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

✕

Access Insights for BioNTech SE and Millions of Other Companies

Sign up for full access to BioNTech SE information.
No credit card needed
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.